APA (7th ed.) Citation

Bo, J., Lei, Z., Zhang, S., He, M., Huang, X., She, B., . . . Yi, X. (2025). Diagnostic efficacy and subgroup heterogeneity of SHOX2, RASSF1A, Septin9, and HOXA9 methylation in pleural effusion lymphoma. Clinical Epigenetics, 17(1), 1. https://doi.org/10.1186/s13148-025-01996-9

Chicago Style (17th ed.) Citation

Bo, Jiaqi, et al. "Diagnostic Efficacy and Subgroup Heterogeneity of SHOX2, RASSF1A, Septin9, and HOXA9 Methylation in Pleural Effusion Lymphoma." Clinical Epigenetics 17, no. 1 (2025): 1. https://doi.org/10.1186/s13148-025-01996-9.

MLA (9th ed.) Citation

Bo, Jiaqi, et al. "Diagnostic Efficacy and Subgroup Heterogeneity of SHOX2, RASSF1A, Septin9, and HOXA9 Methylation in Pleural Effusion Lymphoma." Clinical Epigenetics, vol. 17, no. 1, 2025, p. 1, https://doi.org/10.1186/s13148-025-01996-9.